QDEL
QuidelOrtho Corporation
QDEL offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over QDEL overall, supported by lower modeled downside and stronger modeled upside.
QDEL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Weak |
QDEL's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
QDEL PE Valuation
QDEL has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
QDEL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect QDEL's profitability to improve, but its revenue to decline.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
UNH has the edge over QDEL on the outlook, with more favorable earnings and revenue expectations.
QDEL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.90 | — |
| Q3 2026 | -$5.44 | +$11.84 |
| Q2 2026 | -$15.44 | -$8.64 |
| Q1 2026 | -$17.85 | -$12.62 |
| Q4 2025 | -$16.69 | +$13.85 |
| Q3 2025 | -$17.28 | +$10.61 |
| Q2 2025 | -$6.80 | +$20.98 |
| Q1 2025 | -$5.23 | +$21.15 |
| Q4 2024 | -$30.54 | -$30.39 |
QDEL is still losing money, but far less than before: $5.44 per share over the past year, against $30.54 at its worst in late 2024.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over QDEL on earnings quality, reporting a profit while its opponent remains loss making.
QDEL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $618.9M | -12% |
| Q2 2026 | $630.9M | +2.8% |
| Q1 2026 | $619.8M | -11% |
| Q4 2025 | $723.6M | +2.2% |
| Q3 2025 | $699.9M | -3.7% |
| Q2 2025 | $613.9M | -3.6% |
| Q1 2025 | $692.8M | -2.6% |
| Q4 2024 | $707.8M | -4.7% |
QDEL's revenue has slid since its 2022 peak: $619M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.2% | +100 points |
| Q2 2026 | -3.5% | +26 points |
| Q1 2026 | -5.1% | -9.8 points |
| Q4 2025 | -9.2% | +5 points |
| Q3 2025 | -101% | -103 points |
| Q2 2025 | -29% | -11 points |
| Q1 2025 | 4.7% | +252 points |
| Q4 2024 | -14% | -20 points |
QDEL's operating margin was −1.2% last quarter, up 99 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over QDEL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over QDEL on profitability, with a higher operating margin.
QDEL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4M | +$93.3M |
| Q2 2026 | -$136.1M | -$51.8M |
| Q1 2026 | -$67M | -813% |
| Q4 2025 | $86.6M | +425% |
| Q3 2025 | -$94.7M | -233% |
| Q2 2025 | -$84.3M | +$48.9M |
| Q1 2025 | $9.4M | +$76.2M |
| Q4 2024 | $16.5M | -48% |
QDEL's free cash flow was −$118M over the past year, against −$153M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over QDEL on cash generation, producing positive trailing cash flow while its opponent burns cash.
QDEL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.3x | High |
| Q2 2025 | 11.9x | High |
| Q1 2025 | 8.6x | High |
| Q4 2023 | 3.9x | Elevated |
| Q3 2023 | 3.9x | Elevated |
| Q2 2023 | 3.8x | Elevated |
| Q1 2023 | 3.5x | Elevated |
| Q4 2022 | 2.3x | Moderate |
QDEL's net debt is about 8.3 years of its operating earnings (EBITDA), up from 3.9 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over QDEL on leverage, with a lower net debt burden relative to earnings.
QDEL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 20.9 | Neutral |
QDEL's weekly RSI is 39 (neutral) and its Stochastic is 21 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
QDEL PE vs Healthcare Sector
| Metric | QDEL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
QDEL has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
QDEL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.0 | 12% below |
| 20 week MA | $13.8 | 23% below |
| 50 week MA | $17.5 | 39% below |
| 100 week MA | $24.8 | 57% below |
| 200 week MA | $43.7 | 76% below |
QDEL is in a downtrend: it's below all five of its weekly moving averages, and 76% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over QDEL on trend strength, trading above more of its moving averages.
QDEL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $74.3 | $197.5 | +166% |
| 2021 | $197.5 | $137.4 | -30% |
| 2022 | $137.4 | $84.7 | -38% |
| 2023 | $84.7 | $73.7 | -13% |
| 2024 | $73.7 | $44.3 | -40% |
| 2025 | $44.3 | $29.3 | -34% |
| 2026 YTD | $29.3 | $10.6 | -64% |
QDEL has finished five years in a row lower, and it's down 64% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over QDEL on returns for 2026, with the stronger performance.